| Date | Time | Source | Headline | Symbol | Company |
| 03/26/2013 | 9:31AM | PR Newswire (US) | Critical Alerts For Lowe's, Apollo Group, Darden Restaurants, Onyx Pharmaceuticals, and Ocwen Financial Released By Investors... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/26/2013 | 9:17AM | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/26/2013 | 6:54AM | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/25/2013 | 5:16PM | PR Newswire (US) | Bayer's Stivarga® (regorafenib) Tablets Approved in Japan | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/21/2013 | 3:40PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/18/2013 | 8:00AM | PR Newswire (US) | Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Ale... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/15/2013 | 3:52PM | Dow Jones News | UPDATE: Onyx Pharmaceuticals CEO: Seeking Acquisition Targets | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/15/2013 | 12:40PM | Dow Jones News | Onyx Pharmaceuticals CEO: Seeking Acquisition Targets | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/13/2013 | 7:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/13/2013 | 7:41PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/13/2013 | 7:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/13/2013 | 7:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/12/2013 | 10:00AM | Marketwired | Perfect Trade Setups, How to Play NKE, CCL, LMT and ONXX | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/12/2013 | 10:00AM | GlobeNewswire Inc. | ONYX Pharmaceuticals, Inc. [ONXX] to Ring The NASDAQ Stock Market Opening Bell | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/11/2013 | 5:51PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/11/2013 | 5:50PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/11/2013 | 5:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/11/2013 | 8:43AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/04/2013 | 6:40PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/28/2013 | 5:20PM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/27/2013 | 4:00PM | Marketwired | Onyx Pharmaceuticals to Host Analyst Day March 14, 2013 | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/25/2013 | 4:05PM | PR Newswire (US) | Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Patients with Locally Advanced, Unresectable o... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/22/2013 | 6:40AM | Zacks | Onyx Tops Expectations - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/21/2013 | 4:12PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/21/2013 | 4:00PM | Marketwired | Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2012 Financial Results | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/20/2013 | 8:30AM | Marketwired | Onyx Pharmaceuticals Announces Carfilzomib Study Published in the Medical Journal Leukemia Study Assessed Impact of Renal Fun... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/15/2013 | 8:30AM | Marketwired | Onyx Pharmaceuticals Appoints Dr. Pablo Cagnoni as Executive Vice President, Global Research & Development and Technical Oper... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/14/2013 | 2:21PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/14/2013 | 12:52PM | Edgar (US Regulatory) | Schedule 13g | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/14/2013 | 9:31AM | PR Newswire (US) | Critical Alerts For Verizon, United Continental, Garmin, Onyx Pharmaceuticals, and Darden Restaurants Released By InvestorsOb... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |